Johns Hopkins University
Clinical trials sponsored by Johns Hopkins University, explained in plain language.
-
Brain pacemaker for tics? tiny study explores DBS for Tourette's
Disease control TerminatedThis early-phase study tested whether deep brain stimulation (DBS) could help people with severe Tourette syndrome that doesn't improve with medication. Researchers placed tiny electrodes in a brain area called the thalamus to try to calm abnormal signals that cause tics. Only 2 …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
COVID-19 drug trial halted early – too few volunteers
Symptom relief TerminatedThis study aimed to see if the drug emetine could help people with COVID-19 feel better faster and avoid hospitalization. It was designed for adults 30 and older with mild to moderate symptoms. However, the trial was stopped early after only 4 people enrolled, so we cannot say if…
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 01, 2026 15:56 UTC
-
Brainwave training shows promise for aphasia communication
Symptom relief TerminatedThis study tested whether EEG neurofeedback training can improve communication, anxiety, and sleep in people with aphasia (trouble speaking or understanding language) caused by stroke or primary progressive aphasia. Seven adults participated, receiving both real and sham (fake) n…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Apr 29, 2026 15:05 UTC
-
At-Home brain zaps aim to boost thinking in dementia patients
Symptom relief TerminatedThis study tested whether a non-invasive brain stimulation technique called tDCS, done at home, could improve thinking and language skills in people with primary progressive aphasia, mild cognitive impairment, or dementia. Participants used a headset to stimulate a key brain area…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Apr 29, 2026 15:04 UTC